Haemonetics Corp. buy Citigroup Inc.
Start price
09.07.25
/
50%
€65.00
Target price
09.07.26
€76.78
Performance (%)
-30.77%
Price
12.05.26
€46.00
Summary
This prediction is currently active. Massive losses of -30.77% have been the result for the BUY prediction by Citigroup_Inc_. This prediction currently runs until 09.07.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | -3.361% | -3.361% |
| iShares Core DAX® | -1,52 % | 0,86 % |
| iShares Nasdaq 100 | 3,36 % | 15,64 % |
| iShares Nikkei 225® | 1,66 % | 8,64 % |
| iShares S&P 500 | 1,61 % | 8,53 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Corporation (NYSE: HAE) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $90.00 price target on the stock.
Ratings data for HAE provided by MarketBeat